Paddington Life Sciences Partners will be a key driver of the Paddington Life Sciences development.
Paddington Life Sciences Partners is a partnership group - made up of NHS, industry, community and academic organisations - with a shared commitment to generating healthcare innovation, alongside health, economic and social value, through a new life sciences cluster centred around St Mary’s Hospital in Paddington.
Members of Paddington Life Sciences Partners have committed to, and are investing in, developing a life sciences cluster in Paddington that achieves major health, social and economic value. There are also associate members that have a strategic advisory role and may also support specific projects.
Paddington Life Sciences Partners are: British Land, Brockton Everlast, Derwent London, Imperial College Healthcare NHS Trust, Imperial College London, IQVIA, Microsoft, Optum, Oracle Health, Takeda, The Paddington Partnership, Vertex and Vodafone. The Associate Partners are: Imperial College Health Partners and Imperial Health Charity.
OUR WORK STREAMS
Paddington Life Sciences Partners have agreed to work together to improve health and reduce inequalities through four key areas of focus:
Supporting local communities and tackling inequalities through community engagement, increasing access to education and employment, and improving digital inclusion.
Diversity and inclusion in clinical trials
Working with local communities to co-produce approaches to increasing diversity in clinical trials and to influence clinical research practice, such as by training and supporting community champions.
Data and digital
Using collective data analytics expertise, secure data environments and real-world evidence to improve care.
Place and space
Promoting Paddington as a highly desirable location for life sciences business to start, develop and grow.